RHEUMATOLOGY WITH KARTILAGE® and KARTILAGE® CROSS

Viscosupplementation with hyaluronic acid is now a therapeutic option that can be offered to patient suffering from pain or reduced joint mobility of degenerative (arthritis of the knee or hip) or traumatic aetiology (accidental or sports injury), especially if NSAIDs and other analgesics have proven ineffective and in subjects who refuse or are not eligible for surgery.

Laboratoires VIVACY has developed a special range of hyaluronic acid based visco-supplements, KARTILAGE® and KARTILAGE® CROSS, with the benefits of a natural antioxidant mannitol to restore, improve and maintain joint function for a better quality of life and overall well-being.

KARTILAGE®

stylage classic range

KARTILAGE® is a three-dose injection of a solution of sodium hyaluronate (15.5mg/g) and mannitol over three weeks (one injection per week). Two different kinds of packaging are available for KARTILAGE®: 2 ml syringes are designed for joints such as the ankle, shoulder, knee or hip, and 1 ml syringes are available for smaller joints such as in the hands and feet.

ADVANTAGES

  • Suitable for all patients.
  • First-line treatment.
  • Maintenance treatments and monitoring.

KARTILAGE® CROSS – SINGLE INJECTION

stylage classic range

KARTILAGE® CROSS is a single intra-articular injection treatment that uses the patented IPN-Like Technology of hyaluronic acid cross-linking with the benefits of the antioxidant mannitol. It has been specifically designed by Laboratoires VIVACY to relieve the pain of osteoarthritis in joints (e.g. knee, hip, etc.), notably after failure or intolerance of pain killers (AINS, AIS), and any pain or limited joint mobility from degenerative or traumatic origin. KARTILAGE® CROSS works by restoring the lubricating and shock-absorbing properties of joint fluid, which are depleted in osteoarthritis.

THE IPN-Like TECHOLOGY

stylage classic range
  • Ensures longevity of the product in the joint.
  • Guarantees optimum viscoelasticity for shock absorption.
  • Facilitates injection into all joint-related lesions.

ADVANTAGES

  • Recommended for patients who cannot comply with post-injection rest periods three weeks in a row.
  • Who dislike injections or want to minimise the number of injections.
  • Whose joints are difficult to access.
KARTILAGE® and KARTILAGE® CROSS, Medical Devices - Class III – CE Marking No. 0344.

Injection is a medical procedure that requires experience and knowledge.

Consult your doctor (orthopedic surgeon, rheumatologist, physician who has received specific training)
and read carefully the leaflet supplied with each product.